Medication info
Mizartan Plus Tablet 80/12.5 mg (Telmisartan, Hydrochlorothiazide)

Mizartan Plus Tablet 80/12.5 mg (Telmisartan, Hydrochlorothiazide)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
IYUN Pharmaceuticals Co., Ltd.
Appearance
White or off-white elongated tablet
Packaging
30 tablets (10 tablets/Alu-Alu * 3)
Approval status
Active

MFDS item code 201903559 · Approved 2019.05.29 · Insurance code 658604660

Summary

Main use
Treatment of essential hypertension not controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be individually adjusted and administered separately. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered as separate tablets or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution in patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg per day of this medicine. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use 2). Thiazide diuretics should be administered with caution to patients with hepatic dysfunction. Elderly patients No dose adjustment is necessary.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
IYUN Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used for the treatment of essential hypertension. It helps to more effectively control blood pressure when added to patients whose blood pressure is not sufficiently controlled by Telmisartan alone. It manages blood pressure safely and effectively, reducing the risk of complications.

How to take

Adult dose

For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be individually adjusted and administered separately. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered as separate tablets or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution in patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg per day of this medicine. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use 2). Thiazide diuretics should be administered with caution to patients with hepatic dysfunction. Elderly patients No dose adjustment is necessary.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication can pose a significant risk to the fetus, especially during the second and third trimesters of pregnancy, and should be discontinued immediately upon confirmation of pregnancy. This medication should not be administered to patients with an allergy to the active ingredients or additives, pregnant or nursing women, or patients with severe liver or kidney diseases. Elderly patients, those with elevated potassium levels, or patients with weakened liver function, valvular heart disease, or ischemic heart disease should use this medication cautiously. The Hydrochlorothiazide component may sensitize the skin to sunlight, increasing the risk of skin cancer; therefore, sun exposure should be avoided during use, and the skin should be monitored periodically. This medication lowers blood pressure, and symptoms such as dizziness, hypotension, and fainting may occur. Electrolyte imbalances can occur, making it important to regularly check the levels of potassium, sodium, and other electrolytes through blood tests. Particular caution is essential for patients with impaired kidney function or those who are dehydrated or sodium deficient, as there is a risk of hypotension or kidney failure; improving these conditions before taking the medication is crucial. This medication may interact with other antihypertensives, diuretics, lithium, and non-steroidal anti-inflammatory drugs; it is essential to inform healthcare professionals of any medications being taken. Dizziness or drowsiness may occur when driving or operating machinery, so caution is advised, and such activities should be avoided if symptoms are present. Overdose may result in hypotension, electrolyte abnormalities, dehydration, and it is vital to adhere to the recommended dosage; seek immediate medical attention if adverse symptoms occur. This medication is not recommended for use in children under 18 years of age, as its safety and efficacy have not been established.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 117 more
  • dizziness
  • fainting
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver dysfunction
  • liver disorder
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasms
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • elevated uric acid in blood
  • increased blood creatinine
  • increased serum creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • cough
  • dry mouth
  • abdominal discomfort
  • taste disorder
  • eczema
  • drug rash
  • toxic skin rash
  • bone pain
  • renal impairment
  • asthenia
  • increased serum creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • hypomagnesemia
  • hyperlipidemia
  • decreased appetite
  • hyperglycemia
  • hypercalcemia
  • hypochloremic alkalosis
  • headache
  • yellow vision
  • acute myopia
  • angle-closure glaucoma
  • choroidal effusion
  • necrotizing vasculitis
  • acute respiratory distress syndrome
  • nausea
  • pancreatitis
  • jaundice
  • biliary stasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • renal impairment
  • asthenia
  • fever
  • facial flushing
  • malaise
  • fatigue
  • weight loss
  • proteinuria
  • itching
  • myalgia
  • floating sensation
  • lip and hand tremors
  • sensory hyperreactivity
  • gum disease
  • dry lips
  • decreased vision
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and moisture. The storage temperature should be maintained between 1 to 30 degrees Celsius (room temperature). Proper storage will help maintain the medication's efficacy and ensure safe use.

Appearance and packaging

Appearance

White or off-white elongated tablet

Package unit

30 tablets (10 tablets/Alu-Alu * 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.